Monocyte-dependent costimulatory effect of TGF-β1 on rat T-cell activation

Scandinavian Journal of Immunology

Volumn 44, Issue 3, 1996, Pages 252-260

  Schiott A ^a   Sjogren H O ^a   Lindvall, M ^b  

^a LUND UNIVERSITY   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR; STAPHYLOCOCCUS ENTEROTOXIN A; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; FLOW CYTOMETRY; LYMPH NODE CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE CULTURE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

EID: 0029785995     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-308.x     Document Type: Article

References (55)

1. Sporn MB, Roberts AB, Wakefield LM, Assoian RK. Transforming growth factor-β: biological function and chemical structure. Science 1986;233:532-4.
2. Sporn MB, Roberts AB, Wakenfield LM, de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 1987;105:1039-45.
3. Sporn MB, Roberts AB. Peptide growth factors are multifunctional. Nature 1988;332:217-9.
4. Massagué J. The TGF-β family of growth and differentiation factors. Cell 1987;49:437-8.
5. van Obberghen Schilling E, Roche NS, Flanders KC, Sporn MB, Roberts AB. Transforming growth factor beta-1 positively regulates its own expression in normal and transformed cells. J Biol Chem 1988;263:7741-46.
6. Yamamoto H, Hirayama M, Genyea C, Kaplan J. TGF-beta mediates natural suppressor activity of IL-2-activated lymphocytes. J Immunol 1994;152:3842-7.
7. Noble PW, Henson PM, Lucas C, Mora WM, Carre PC, Riches DWH. Transforming growth factor-beta primes macrophages to express inflammatory gene products in response to particulate stimuli by an autocrine-paracrine mechanism. J Immunol 1993;151:979-89.
8. Sulitzeanu D. Immunosuppressive factors in human cancer. In: Vande Woude GF, Klein G, eds. Advances in Cancer Research. San Diego: Academic Press, 1993:247-67.
9. Derynck R, Jarrett JA, Chen EY et al. Human transforming growth factor-beta complementary dna sequence and expression in normal and transformed cells. Nature 1985;316:701-5.
10. Massagué J, Attisano L, Wrana JL. The TGF-beta family and its composite receptors. Trends in Cell Biol 1994;4:172-8.
11. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J. Mechanism of activation of the TGF-β receptor. Nature 1994;370:341-7.
12. Rodriguez C, Chen F, Weinberg RA, Lodish HF. Cooperative binding of transforming growth factor (TGF)-beta-2 to the types I and II TGF-beta receptors. J Biol Chem 1995;270:15919-22.
13. Markowitz S, Wang J, Myeroff L et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellitte instability. Science 1995;268:1336-8.
14. Miyazono K, Olofsson A, Colosetti P, Heldin CH. A role of the latent tgf-beta-1-binding protein in the assembly and secretion of tgf-beta-1. EMBO Journal 1991;10:1091-102.
15. Wahl SM, Mccartney FN, Mergenhagen SE. Inflammatory and immunomodulatory roles of tgf-beta. Immunology Today 1989;10:258-61.
16. Wahl SM, Costa GL, Corcoran M, Wahl LM, Berger AE. Transforming growth factor-beta mediates il-1-dependent induction of il-1 receptor antagonist. J Immunol 1993;150:3553-60.
17. Ellingsworth LR, Nakayama D, Segarini P, Dasch J. Carrillo P, Waegell W. Transforming growth factor-betas are equipotent growth inhibitors of interleukin-1-induced thymocyte proliferation. Cell Immunol 1988;114:41-54.
18. Ristow HJ. Bsc-1 growth inhibitor-type beta transforming growth factor is a strong inhibitor of thymocyte proliferation. Proc Natl Acad Sci USA 1986;83:5531-3.
19. Pietenpol JA, Holt JT, Stein RW, Moses HL. Transforming growth factor beta-1 suppression of c-myc gene transcription role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci USA 1990;87:3758-62.
20. Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, Fauci AS. Transforming growth factor beta is an important immunomodulatory protein for human b lymphocytes. J Immunol 1986;137:3855-60.
21. Kehrl JH, Taylor AS, Delsing GA, Roberts AB, Sporn MB, Fauci AS. Further studies of the role of transforming growth factor-beta in human b cell function. J Immunol 1989;143:1868-74.
22. Ranges GE, Figari IS, Espevik T, Palladino MAJ. Inhibition of cytotoxic t cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J Exp Med 1987;166:991-8.
23. Brooks B, Chapman K, Lawry J, Meager A, Rees RC. Suppression of lymphokine-activated killer lak cell induction mediated by interleukin-4 and transforming growth factor-beta-1 effect of addition of exogenous tumor necrosis factor-alpha and interferon-gamma and measurement of their endogenous production. Clin Exp Immunol 1990;82:583-9.
24. Fox FE, Capocasale RJ, Ford HC, Lamb RJ, Moore JS, Nowell PC. Transforming growth factor-beta inhibits human t-cell proliferation through multiple targets. Lymphokine Cytokine Res 1992;11:299-305.
25. Holter W, Kalthoff FS, Picki WF et al. Transforming growth factor-β inhibits IL-4 and IFN-gamma production by stimulated human T cells. Int Immunol 1994;6:469-75.
26. Kehrl JH, Wakefield LM, Roberts AB et al. Production of transforming growth factor-beta by human t lymphocytes and its potential role in the regulation of t cell growth. J Exp Med 1986;163:1037-50.
27. Ahuja SS, Paliogianni F, Yamada H, Balow JE, Boumpas DT. Effect of Transforming Growth Factor-β on Early and Late Activation Events in Human T Cells. J Immunol 1993;150:3109-18.
28. Fox FE, Ford HC, Douglas R, Cherian S, Nowell PC. Evidence that tgf-heta can inhibit human t-lymphocyte proliferation through paracrine and autocrine mechanisms. Cell Immunol 1993;150:45-58.
29. Satterwhite DJ, Moses HL. Mechanisms of transforming growth factor-beta 1-induced cell cycle arrest. Invasion Metastasis 1994;14:1994-5.
30. Kato JY, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. Direct binding of cyclin d to the retinoblastoma gene product prb and prb phosphorylation by the cyclin d-dependent kinase cdk4. Genes Dev 1993;7:331-42.
31. Kim PH, Kagnoff ME. Transforming growth factor-beta-1 is a costimulator for iga production. J Immunol 1990;144:3411-6.
32. Cerwenka A, Bevec D, Majdic O, Knapp W, Wolfgang H. TGF-β1 is a potent inducer of human effector T cells. J Immunol 1994;153:4367-77.
33. Lee HM. Rich S. Differential activation of cd8 positive t cells by transforming growth factor-beta-1. J Immunol 1993;151:668-77.
34. Lee HM. Rich S. Co-stimulation of 1 cell proliferation by transforming growth factor- beta-1. J Immunol 1991;147:1127-33.
35. Rich S, Seelig M, Lee H-M. Lin J. Transforming growth factor β1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8 + T cells. J Immunol 1995;155:609-18.
36. Kondo S, Isobe K, Ishiguro N, Nakashima I, Miura T. Transforming growth factor-beta-1 enhances the generation of allospecific cytotoxic t lymphocytes. Immunology 1993:79:459-64.
37. Swain SL, Huston G, Tonkonogy S, Weinberg A. Transforming growth factor-beta and il-4 cause helper t cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J Immunol 1991;147:2991-3000.
38. de Jong R, Van LRAW, Ruscetti FW, Schmitt C, Debre P, Mossalayi MD. Differential effect of transforming growth factor-beta-1 on the activation of human naive and memory CD4+ T lymphocytes. Int Immunol 1994;6:631-8.
39. Ackerman SK, Douglas SD. Purification of human monocytes on micro exudate coated surfaces. J Immunol 1978;120:1372-74.
40. Islam LN, Wilkinson PC. Evaluation of methods for isolating human peripheral blood monocytes studies on chemotactic locomotion and other functional characteristics. J Immunol Methods 1989l;121:75-84.
41. Warwick DJ, Lowrie DB, Cole PJ. Selective deactivation of human monocyte functions by TGF-heta. J Immunol 1995;155:3186-93.
42. Kramer IM, Patel R, Spargo D, Riley P. Initiation of growth inhibition by TGF-beta-1 is unlikely to occur in G-1. J Cell Science 1994;107:3469-75.
43. Mazars P, Barboule N, Baldin V, Vidai S, Ducommun B, Valette A. Effects of TGF-beta-1 (transforming growth factor-beta-1) on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells. FEBS Lett. 1995;362:295-300.
44. Reddy KB, Hocevar BA, Howe PH. Inhibition of G1 phase cyclin dependent kinases by transforming growth factor beta-1. J Cell Biochem 1994;56:418-25.
45. Sherr CJ. Mammalian g-1 cyclins. Cell 1993;73:1059-65.
46. Ko TC, Sheng HM, Reisman D, Thompson EA, Beauchamp RD. Transforming growth factor-beta-1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene 1995;10:177-84.
47. Slingerland JM, Hengst L, Pan CH, Alexander D, Stampfer MR, Reed SI. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol Cell Biol 1994;14:3683-94.
48. Polyak K, Kato JY, Solomon MJ et al. P27-Kipl, a cyclin-Cdk inhibitors, links transforming growth factor- beta and contact inhibition to cell cycle arrest. Genes Dev 1994;8:9-22.
49. Polyak K, Lee MH, Erdjument BH et al. Cloning of p27-Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994;78:59-66.
50. Toyoshima H, Hunter T. P27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994;78:67-74.
51. Ravitz MJ, Yan S, Herr KD, Wenner CE. Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27-Kip1 in C3H 10T1-2 mouse fibroblasts. Cancer Res 1995;55:1413-16.
52. Kletsas D, Stathakos D, Sorrentino V, Philipson L. The growth-inhibitory block of TGF-beta is located close to the G1-S border in the cell cycle. Exp Cell Res 1995;217:477-83.
53. Yan Z, Winawer S, Friedman E. Two different signal transduction pathways can be activated by transforming growth factor beta-1 in epithelial cells. J Biol Chem 1994;269:13231-7.
54. Mulder KM, Morris SL. Activation of p21-ras by transforming growth factor beta in epithelial cells. J Biol Chem 1992;267:5029-31.
55. Bassing CH, Yingling JM. Wang XF. Receptors of the TGF-beta ligand family. In: Litwack G, ed. Vitamins and Hormones: Advances in Research and Applications. San Diego: Academic Press, 1994:111-56.